Criminal trial against René Benko: What awaits us in Innsbruck?

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

The criminal trial against René Benko, founder of Signa, begins on October 14, 2025 at the Innsbruck regional court. Context of the charge: Fraudulent Krida.

Der Strafprozess gegen René Benko, Gründer von Signa, beginnt am 14. Oktober 2025 am Landesgericht Innsbruck. Kontext der Anklage: Betrügerische Krida.
The criminal trial against René Benko, founder of Signa, begins on October 14, 2025 at the Innsbruck regional court. Context of the charge: Fraudulent Krida.

Criminal trial against René Benko: What awaits us in Innsbruck?

Things are boiling in the Austrian judicial world: On October 14th and 15th, René Benko, the controversial founder of the real estate company Signa, will appear before the regional court in Innsbruck. The hearing begins at 9 a.m. on both days and will last until 6 p.m. on the first day and until 8 p.m. on the second day. Benko is charged with fraudulent Krida, in which he is accused of preventing or reducing the satisfaction of creditors' claims by setting aside assets in the course of his bankruptcy. The alleged damage amount is an impressive 660,000 euros. If he is convicted, he could face prison sentences of between one and ten years, which could represent a dark chapter for the real estate tycoon.

Rumors about the trial have been circulating for some time, and his lawyer had even requested that the trial be moved to Vienna. However, this request was rejected. A circumstance that is further fueling public attention is the fact that Benko has been in custody at the Vienna-Josefstadt prison since January 24th. Apparently his stay there will be more than just a temporary affair.

Health in focus

Parallel to the legal disputes, another topic is emerging that is important for many people in everyday life: heart health. Cardiac arrhythmias are common and are usually diagnosed through extensive examinations. Common methods include electrocardiograms (ECG), which measure the electrical activity of the heart. For longer monitoring, some people use wearable solutions such as the Holter monitor or event recorder, which record heart activity for up to 30 days.

Treatment approaches vary depending on the type of arrhythmia. In some cases, no medical intervention is required, while other forms require more intensive monitoring or even surgery. A heart-healthy lifestyle that includes a balanced diet as well as regular exercise plays a crucial role in preventing heart disease.

Protective measures in the workplace

The requirements for the masks and the execution of the fit tests are clearly regulated. For example, no measurement results may be left behind if the user has weight or facial changes that could affect the fit of the mask. Compliance with these regulations is not only a legal obligation, but also a question of responsibility towards employees.